Inês Ribeiro‐Vaz
Impact in
- Toxicology top 0.5%
- Pharmacovigilance and Adverse Drug Reactions
- Geriatrics and Gerontology top 2%
- Pharmaceutical Practices and Patient Outcomes
Papers in
- Toxicology 28
- Pharmacovigilance and Adverse Drug Reactions 28
-
- Pharmaceutical studies and practices 12
- Co-authors
- Jorge Polónia (24 shared papers)Ricardo Cruz‐Correia (6 shared papers)María Teresa Herdeiro (13 shared papers)Altamiro Costa‐Pereira (5 shared papers)Cristina Santos (6 shared papers)Adolfo Figueiras (4 shared papers)Eva Gómes (3 shared papers)Andréia Teixeira (5 shared papers)
- Journals
- Drug Safety (5 papers)International Journal of Clinical Pharmacy (4 papers)Frontiers in Medicine (2 papers)Expert Opinion on Drug Safety (2 papers)BMJ Open (2 papers)
- Partner nations
- PortugalUnited StatesBrazil
In The Last Decade
Inês Ribeiro‐Vaz
46 papers receiving 726 citations
Peers
Comparison fields: 5 of 103
- Toxicology 289
- Geriatrics and Gerontology 134
- Family Practice 36
- Pharmacology 147
- Applied Microbiology and Biotechnology 16
Countries citing papers authored by Inês Ribeiro‐Vaz
This map shows the geographic impact of Inês Ribeiro‐Vaz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Inês Ribeiro‐Vaz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Inês Ribeiro‐Vaz more than expected).
Fields of papers citing papers by Inês Ribeiro‐Vaz
This network shows the impact of papers produced by Inês Ribeiro‐Vaz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Inês Ribeiro‐Vaz. The network helps show where Inês Ribeiro‐Vaz may publish in the future.
Co-authors
The 25 scholars most cited alongside Inês Ribeiro‐Vaz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 55 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 184 | |
| 2 | 2012 | 62 | |
| 3 | 2019 | 53 | |
| 4 | 2016 | 52 | |
| 5 | 2012 | 44 | |
| 6 | 2013 | 38 | |
| 7 | 2012 | 33 | |
| 8 | Estratégias para aumentar a sensibilidade da farmacovigilância em Portugal | 2011 | 29 |
| 9 | 2024 | 28 | |
| 10 | 2014 | 28 | |
| 11 | 2018 | 20 | |
| 12 | 2016 | 18 | |
| 13 | 2021 | 14 | |
| 14 | [The Portuguese Pharmacovigilance System]. | 2013 | 13 |
| 15 | 2012 | 13 | |
| 16 | 2022 | 12 | |
| 17 | 2015 | 11 | |
| 18 | 2024 | 10 | |
| 19 | 2022 | 9 | |
| 20 | 2022 | 8 |
About Inês Ribeiro‐Vaz
Inês Ribeiro‐Vaz is a scholar working on Toxicology, Pediatrics, Perinatology and Child Health, Pharmacology, Geriatrics and Gerontology and Infectious Diseases, having authored 55 papers that have together received 746 indexed citations. Recurring topics across this work include Pharmacovigilance and Adverse Drug Reactions (28 papers), Pharmaceutical studies and practices (12 papers), Pharmaceutical Practices and Patient Outcomes (11 papers), Drug-Induced Adverse Reactions (8 papers), Pharmaceutical Economics and Policy (7 papers), Academic integrity and plagiarism (6 papers), COVID-19 Clinical Research Studies (6 papers) and SARS-CoV-2 and COVID-19 Research (6 papers). The work is most often cited by research in Toxicology (289 citations), Geriatrics and Gerontology (134 citations), Family Practice (36 citations), Pharmacology (147 citations) and Applied Microbiology and Biotechnology (16 citations). Inês Ribeiro‐Vaz has collaborated with scholars based in Portugal, United States and Brazil. Frequent co-authors include Jorge Polónia, Ricardo Cruz‐Correia, María Teresa Herdeiro, Altamiro Costa‐Pereira, Cristina Santos, Adolfo Figueiras, Eva Gómes, Andréia Teixeira, Matilde Monteiro‐Soares and Pascal Demoly. Their work appears in journals such as Drug Safety, International Journal of Clinical Pharmacy, Frontiers in Medicine, Expert Opinion on Drug Safety and BMJ Open.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.